0001104659-21-084957.txt : 20210723 0001104659-21-084957.hdr.sgml : 20210723 20210624113702 ACCESSION NUMBER: 0001104659-21-084957 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevation Oncology, Inc. CENTRAL INDEX KEY: 0001783032 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 841771427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6380 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 FORMER COMPANY: FORMER CONFORMED NAME: 14ner Oncology, Inc. DATE OF NAME CHANGE: 20190719 CORRESP 1 filename1.htm

 

Elevation Oncology, Inc. 

888 Seventh Avenue, 12th Floor 

New York, NY 10106

 

June 24, 2021

 

VIA EDGAR

 

United States Securities and Exchange Commission
Division of Corporation Finance 

100 F Street, NE
Washington, DC 20549

 

Attention:

 

Christopher Edwards

Deanna Virginio

Gary Newberry

Kevin Kuhar

   
Re:

Elevation Oncology, Inc. Registration Statement on Form S-1 (File No. 333-256787) originally filed June 4, 2021, as amended, and corresponding Registration Statement on Form 8-A (File No. 001-40523) filed June 21, 2021

 

Requested Date: June 24, 2021 

Requested Time: 4:30 PM Eastern Time

 

Ladies and Gentlemen:

 

Elevation Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to declare the above-captioned Registration Statements on Form S-1 and Form 8-A effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.

 

The Registrant hereby authorizes Robert A. Freedman or Julia Forbess, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.

 

The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, Ms. Forbess at (415) 875-2420.

 

* * *

 

 

 

  Sincerely,
   
  Elevation Oncology, Inc.
   
  By: /s/ Shawn Leland
    Shawn Leland, Pharm. D., R.Ph.
    President and Chief Executive Officer

 

cc:Effie Toshav, Esq.
 Robert A. Freedman, Esq.
 Julia Forbess, Esq.
 Fenwick & West LLP

 

[Signature Page to Company Acceleration Request Letter]